RCE in Evolucare Ecs Imaging
CVE-2021-3029
EVOLUCARE ECSIMAGING (aka ECS Imaging) through 6.21.5 has an OS Command Injection vulnerability via shell metacharacters and an IFS manipulation. The parameter "file" on the webpage /showfile.php can be exploited to gain root access. NOTE: This vulnerability only affects products that are no longer supported by the maintainer
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.031 (87.2th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 87th percentile — 87.2% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.030 · newest: 0.031 · change: +0.000
Affected products
Weakness classification (CWE)
Public proof-of-concept exploits
References
- www.evolucare.com (Product)
- shoxxdj.fr/ecsimaging-os-injection-cve-2021-3029/ (Third Party Advisory)
Frequently asked questions
- What is CVE-2021-3029?
- CVE-2021-3029 is a critical-severity vulnerability in Evolucare Ecs Imaging, classified under OS Command Injection. CVSS score: 9.8/10. Published 2021-01-07.
- How severe is CVE-2021-3029?
- Critical severity. CVSS v3 base score is 9.8 out of 10.
- Is CVE-2021-3029 known to be exploited?
- 6 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.